Published in Arterioscler Thromb Vasc Biol on February 01, 1999
Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood (2015) 1.48
Sequential regulation of the small GTPase Rap1 in human platelets. Mol Cell Biol (2000) 1.32
Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci (2013) 0.84
Site-specific phosphorylation of platelet focal adhesion kinase by low-density lipoprotein. Biochem J (2003) 0.80
Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets. Biochem J (2000) 0.80
Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide. Exp Neurol (2015) 0.75
Possible regulation of platelets by native and modified low density lipoprotein-cholesterol particles. Korean Circ J (2012) 0.75
Evening primrose oil ameliorates platelet aggregation and improves cardiac recovery in myocardial-infarct hypercholesterolemic rats. Int J Physiol Pathophysiol Pharmacol (2014) 0.75
Images in clinical medicine. Heparin-induced skin necrosis. N Engl J Med (1996) 3.30
Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J (1997) 3.23
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Localization of acid phosphatase in protoplasts from Saccharomyces cerevisiae. J Bacteriol (1975) 2.06
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Graft-versus-myeloma effect in two cases. Lancet (1996) 1.80
Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun (1997) 1.76
Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta (1980) 1.59
Activation of the small GTPase Ral in platelets. Mol Cell Biol (1998) 1.58
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis (1993) 1.45
[Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary]. Ned Tijdschr Geneeskd (2003) 1.42
How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis (2001) 1.41
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
Activation of sodium-proton exchange is a prerequisite for Ca2+ mobilization in human platelets. Nature (1987) 1.39
Dual regulation of platelet protein kinase B. J Biol Chem (2000) 1.37
Sequential regulation of the small GTPase Rap1 in human platelets. Mol Cell Biol (2000) 1.32
Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation (2003) 1.28
The origin of P-selectin as a circulating plasma protein. Thromb Haemost (1997) 1.25
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood (1987) 1.18
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.18
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology (2001) 1.11
Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke (1997) 1.11
The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J Biol Chem (1995) 1.10
Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood (1991) 1.05
Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost (1996) 1.03
Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol (2001) 1.02
Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit. Biochem J (1996) 0.99
Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J Biol Chem (1994) 0.98
Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood (1997) 0.98
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost (1987) 0.97
Protein kinase C enhances Ca2+ mobilization in human platelets by activating Na+/H+ exchange. J Biol Chem (1988) 0.97
Metabolic energy is required in human platelets at any stage during optical aggregation and secretion. Biochim Biophys Acta (1984) 0.96
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest (1994) 0.96
A novel technique for rapid determination of energy consumption in platelets. Demonstration of different energy consumption associated with three secretory responses. Biochem J (1983) 0.95
Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol (1997) 0.95
C-peptide. Diabetes Care (1983) 0.95
Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. Biochem J (1991) 0.95
Reactome - a curated knowledgebase of biological pathways: megakaryocytes and platelets. J Thromb Haemost (2012) 0.94
Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption. Biochem J (1984) 0.94
Determination of levels of glycolytic intermediates and nucleotides in platelets by pulse-labeling with [32P]orthophosphate. Anal Biochem (1983) 0.94
Rapid separation of cytosol and particle fraction of human platelets by digitonin-induced cell damage. Br J Haematol (1980) 0.93
Expression of transient receptor potential mRNA isoforms and Ca(2+) influx in differentiating human stem cells and platelets. Biochim Biophys Acta (2001) 0.93
Cleavage of the actin-capping protein alpha -adducin at Asp-Asp-Ser-Asp633-Ala by caspase-3 is preceded by its phosphorylation on serine 726 in cisplatin-induced apoptosis of renal epithelial cells. J Biol Chem (2000) 0.93
Inhibition of platelet integrin alpha(IIb)beta(3) by peptides that interfere with protein kinases and the beta(3) tail. Arterioscler Thromb Vasc Biol (2000) 0.92
The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis. J Thromb Haemost (2003) 0.92
Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. Eur J Haematol (1997) 0.92
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J (1984) 0.92
LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscler Thromb (1994) 0.91
The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost (2001) 0.90
Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood (1995) 0.90
Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays. Biochim Biophys Acta (2008) 0.90
Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut (1990) 0.89
Signal transduction through trimeric G proteins in megakaryoblastic cell lines. Arterioscler Thromb Vasc Biol (1997) 0.89
Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. J Biol Chem (1986) 0.89
Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees. Leukemia (2012) 0.89
Platelet adhesion to collagen. Thromb Haemost (1995) 0.89
Human platelets secrete chemotactic activity for eosinophils. Blood (1993) 0.88
Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost (1996) 0.88
Extracellular and intracellular magnesium concentrations in asthmatic patients. Eur Respir J (1993) 0.88
A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol (1992) 0.88
Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Expression of GMP-140 and LIMP-CD63 (CD63 antigen) in human lymphoid tissues. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.88
Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88
Differential involvement of tyrosine and serine/threonine kinases in platelet integrin alphaIIbbeta3 exposure. Arterioscler Thromb Vasc Biol (1998) 0.88
Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost (1991) 0.88
Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87
Platelet aggregation and Ca2+ secretion are independent of simultaneous ATP production. FEBS Lett (1979) 0.87
High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol (1995) 0.87
A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group. Blood (1993) 0.86
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science (1987) 0.86
Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Hum Genet (2000) 0.86
Thrombocytopenia and the neglected megakaryocyte. N Engl J Med (1992) 0.86
Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study. Atherosclerosis (1996) 0.86
Relation between membrane fluidity and signal transduction in the human megakaryoblastic cell line MEG-01. Biochim Biophys Acta (1995) 0.86
Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J Am Soc Nephrol (2001) 0.86
Regulation of carbohydrate metabolism in platelets. A review. Thromb Haemost (1978) 0.86
Na+/H+ exchange modulates Ca2+ mobilization in human platelets stimulated by ADP and the thromboxane mimetic U 46619. J Biol Chem (1990) 0.86
Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem (1995) 0.85
Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin. Blood (1992) 0.85
Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb Haemost (1999) 0.85
Maturation of megakaryoblastic cells is accompanied by upregulation of G(s)alpha-L subtype and increased cAMP accumulation. Thromb Haemost (1998) 0.85
Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro. J Biol Chem (1993) 0.85